Insider · CIK 0001235952

MAKOWER JOSHUA

Reports to the SEC for 28 companies · TIMONIUM, MD

sec.gov

Transactions

Companies

Filings

CIK

0001235952

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-10-12	Eargo, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+74.1K sh	—	—	74,074
2022-08-23	Eargo, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+74.8K sh	—	—	74,805
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+38.1M sh	—	—	44,001,915
2021-06-28	NEUENeueHealth, Inc. · Series D PreferredC Conversion	10% Owner	CConversion	−12.7M sh	—	—	0
2021-06-28	GLUEMonte Rosa Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+1.05M sh	$19.00	+$20M	7,692,298
2021-06-28	GLUEMonte Rosa Therapeutics, Inc.C Conversion	10% Owner	CConversion	+3.26M sh	—	—	5,973,296
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+10.6M sh	—	—	57,461,346
2021-06-28	GLUEMonte Rosa Therapeutics, Inc. · Series B convertible preferred stockC Conversion	10% Owner	CConversion	−11.5M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc. · Series E PreferredC Conversion	10% Owner	CConversion	−1.22M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+3.33M sh	—	—	107,041,764
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+26.7M sh	—	—	84,164,844
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+19.5M sh	—	—	103,713,912
2021-06-28	NEUENeueHealth, Inc. · Series D PreferredC Conversion	10% Owner	CConversion	−1.11M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc. · Series A PreferredC Conversion	10% Owner	CConversion	−15.6M sh	—	—	0
2021-06-28	GLUEMonte Rosa Therapeutics, Inc. · Series C convertible preferred StockC Conversion	10% Owner	CConversion	−2.36M sh	—	—	0
2021-06-28	GLUEMonte Rosa Therapeutics, Inc.C Conversion	10% Owner	CConversion	+669K sh	—	—	6,642,298
2021-06-28	GLUEMonte Rosa Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.72M sh	—	—	2,715,968
2021-06-28	NEUENeueHealth, Inc. · Series E PreferredC Conversion	10% Owner	CConversion	−2.45M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc. · Series C PreferredC Conversion	10% Owner	CConversion	−1.95M sh	—	—	0
2021-06-28	GLUEMonte Rosa Therapeutics, Inc. · Series A-2 convertible preferred stockC Conversion	10% Owner	CConversion	−9.59M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+7.35M sh	—	—	22,288,629
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+5.86M sh	—	—	5,864,718
2021-06-28	NEUENeueHealth, Inc. · Series D PreferredC Conversion	10% Owner	CConversion	−4.98M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc. · Series D PreferredC Conversion	10% Owner	CConversion	−1.16M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc. · Series C PreferredC Conversion	10% Owner	CConversion	−6.52M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc.P Purchase	10% Owner	PPurchase	+1.69M sh	$18.00	+$30.5M	23,983,073
2021-06-28	NEUENeueHealth, Inc. · Series B PreferredC Conversion	10% Owner	CConversion	−8.9M sh	—	—	0
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+14.9M sh	—	—	14,942,061
2021-06-28	NEUENeueHealth, Inc.P Purchase	10% Owner	PPurchase	+250K sh	$18.00	+$4.5M	47,925,199
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+3.67M sh	—	—	47,675,199
2021-06-28	NEUENeueHealth, Inc.C Conversion	10% Owner	CConversion	+3.49M sh	—	—	3,494,244
2021-06-08	Desktop Metal, Inc.J Other	10% Owner	JOther	−9M sh	—	—	19,263,413
2021-06-08	Desktop Metal, Inc.J Other	10% Owner	JOther	+135K sh	—	—	135,000
2021-06-08	Desktop Metal, Inc.J Other	10% Owner	JOther	+2,285 sh	—	—	2,285
2021-06-08	Desktop Metal, Inc.J Other	10% Owner	JOther	−135K sh	—	—	0
2021-05-24	Eargo, Inc.J Other	Director	JOther	+30K sh	—	—	30,000
2021-05-24	Eargo, Inc.J Other	Director	JOther	−30K sh	—	—	0
2021-05-24	Eargo, Inc.J Other	Director	JOther	−2M sh	—	—	4,520,019
2021-05-24	Eargo, Inc.J Other	Director	JOther	+508 sh	—	—	508
2021-03-16	MRKRMarker Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+5.71M sh	$1.75	+$10M	10,714,285
2020-12-04	Regulus Therapeutics Inc.Class A-3 Convertible Preferred StockP Purchase	Former 10% Owner	PPurchase	+259K sh	$6.22	+$1.61M	258,707
2020-12-04	Regulus Therapeutics Inc.Common Stock Purchase Warrant (right to buy)P Purchase	Former 10% Owner	PPurchase	+5.24M sh	$0.13	+$655K	5,239,254
2020-12-04	Regulus Therapeutics Inc.P Purchase	Former 10% Owner	PPurchase	+4.4M sh	$0.62	+$2.74M	6,451,056
2020-10-20	Eargo, Inc.Series E Preferred StockC Conversion	Director	CConversion	−1.43M sh	—	—	0
2020-10-20	Eargo, Inc.Series D Preferred StockC Conversion	Director	CConversion	−561K sh	—	—	0
2020-10-20	Eargo, Inc.Series C-1 Preferred StockC Conversion	Director	CConversion	−763K sh	—	—	0
2020-10-20	Eargo, Inc.Series C Preferred StockC Conversion	Director	CConversion	−1.27M sh	—	—	0
2020-10-20	Eargo, Inc.Series B-1 Preferred StockC Conversion	Director	CConversion	−547K sh	—	—	0
2020-10-20	Eargo, Inc.P Purchase	Director	PPurchase	+311K sh	$18.00	+$5.6M	6,520,017
2020-10-20	Eargo, Inc.C Conversion	Director	CConversion	+1.43M sh	—	—	6,208,906

Recent filings

Accepted (ET)
Oct 144
MAKOWER JOSHUA0001209191-22-053661
SEC(opens sec.gov)
Aug 254
MAKOWER JOSHUA0001209191-22-047659
SEC(opens sec.gov)
Jun 304
MAKOWER JOSHUA0001209191-21-044195
SEC(opens sec.gov)

Companies

Address

1954 GREENSPRING DRIVE, SUITE 600

TIMONIUM, MD, 21093